Mycophenolate mofetil
Mycophenolate mofetil is a generic prescription drug available as 250 mg oral capsules. It acts as an antimetabolite immunosuppressant, often used to prevent organ rejection in transplant patients. Manufactured by AvKARE under ANDA090055, it comes in bottles of 100 or 500 capsules, with marketing starting May 25, 2025. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Mycophenolate mofetil is a generic prescription drug available as 250 mg oral capsules. It acts as an antimetabolite immunosuppressant, often used to prevent organ rejection in transplant patients. Manufactured by AvKARE under ANDA090055, it comes in bottles of 100 or 500 capsules, with marketing starting May 25, 2025. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Mycophenolate mofetil",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Mycophenolate mofetil — ANDA 212087 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212087"
}
]
|
| identifier | ANDA212087 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Mycophenolate mofetil |
